Cargando…

Broadening the H5N3 Vaccine Immunogenicity against H5N1 Virus by Modification of Neutralizing Epitopes

The highly pathogenic avian influenza (HPAI) H5N1 virus remains to be one of the world’s largest pandemic threats due to the emergence of new variants. The rapid evolution of new sub-lineages is currently the greatest challenge in vaccine development. In this study, we developed an epitope modified...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajesh Kumar, Subaschandrabose, Chelvaretnam, Sharenya, Tan, Yunrui, Prabakaran, Mookkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795415/ https://www.ncbi.nlm.nih.gov/pubmed/29295514 http://dx.doi.org/10.3390/v10010002

Ejemplares similares

Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge
por: kumar, Subaschandrabose Rajesh, et al.
Publicado: (2015)

Development of dual-function ELISA for effective antigen and antibody detection against H7 avian influenza virus
por: He, Fang, et al.
Publicado: (2013)

Progress toward a Universal H5N1 Vaccine: A Recombinant Modified Vaccinia Virus Ankara-Expressing Trivalent Hemagglutinin Vaccine
por: Prabakaran, Mookkan, et al.
Publicado: (2014)

Development of Epitope-Blocking ELISA for Universal Detection of Antibodies to Human H5N1 Influenza Viruses
por: Prabakaran, Mookkan, et al.
Publicado: (2009)

A Novel Peptide ELISA for Universal Detection of Antibodies to Human H5N1 Influenza Viruses
por: Velumani, Sumathy, et al.
Publicado: (2011)

Monoclonal Antibody Targeting Neutralizing Epitope on H5N1 Influenza Virus of Clade 1 and 0 for Specific H5 Quantification
por: He, Fang, et al.
Publicado: (2013)

T cell mediated immunity against influenza H5N1 nucleoprotein, matrix and hemagglutinin derived epitopes in H5N1 survivors and non-H5N1 subjects
por: Noisumdaeng, Pirom, et al.
Publicado: (2021)

Combination Therapy Using Chimeric Monoclonal Antibodies Protects Mice from Lethal H5N1 Infection and Prevents Formation of Escape Mutants
por: Prabakaran, Mookkan, et al.
Publicado: (2009)

Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
por: Premanand, Balraj, et al.
Publicado: (2018)

Mapping Antibody Epitopes of the Avian H5N1 Influenza Virus
por: Yen, Hui-Ling, et al.
Publicado: (2009)

Highly pathogenic avian influenza virus incursions of subtype H5N8, H5N5, H5N1, H5N4, and H5N3 in Germany during 2020-21
por: King, Jacqueline, et al.
Publicado: (2022)

Generation, Characterization and Epitope Mapping of Two Neutralizing and Protective Human Recombinant Antibodies against Influenza A H5N1 Viruses
por: Sun, Lina, et al.
Publicado: (2009)

AS03-adjuvanted H5N1 vaccine promotes antibody diversity and affinity maturation, NAI titers, cross-clade H5N1 neutralization, but not H1N1 cross-subtype neutralization
por: Khurana, Surender, et al.
Publicado: (2018)

The t + n + n System and 5H
por: Meister, M, et al.
Publicado: (2003)

In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination Potential
por: Muñoz-Medina, José Esteban, et al.
Publicado: (2015)

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin
por: Schmeisser, Falko, et al.
Publicado: (2012)

Human H5N2 Avian Influenza Infection in Japan and the Factors Associated with High H5N2-Neutralizing Antibody Titer
por: Ogata, Tsuyoshi, et al.
Publicado: (2008)

Epitope characterization of the protective monoclonal antibody VN04-2 shows broadly neutralizing activity against highly pathogenic H5N1
por: Lim, Angeline PC, et al.
Publicado: (2008)

Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2016)

Intranasal Immunization of Baculovirus Displayed Hemagglutinin Confers Complete Protection against Mouse Adapted Highly Pathogenic H7N7 Reassortant Influenza Virus
por: Rajesh Kumar, Subaschandrabose, et al.
Publicado: (2013)

The Length of N-Glycans of Recombinant H5N1 Hemagglutinin Influences the Oligomerization and Immunogenicity of Vaccine Antigen
por: Macioła, Agnieszka Katarzyna, et al.
Publicado: (2017)

H5N1
por: Petsko, Gregory A
Publicado: (2005)

The Epitope and Neutralization Mechanism of AVFluIgG01, a Broad-Reactive Human Monoclonal Antibody against H5N1 Influenza Virus
por: Cao, Zhiliang, et al.
Publicado: (2012)

Human Avian Influenza A H5N1, H7N9, H10N8 and H5N6 Virus Infection
por: Lu, Pu-Xuan, et al.
Publicado: (2015)

Prediction and Identification of T Cell Epitopes in the H5N1 Influenza Virus Nucleoprotein in Chicken
por: Hou, Yanxia, et al.
Publicado: (2012)

Effects of Size and Surface Properties of Nanodiamonds on the Immunogenicity of Plant-Based H5 Protein of A/H5N1 Virus in Mice
por: Ho, Thuong Thi, et al.
Publicado: (2021)

Inactivated H5 Antigens of H5N8 Protect Chickens from Lethal Infections by the Highly Pathogenic H5N8 and H5N6 Avian Influenza Viruses
por: Jin, Myongha, et al.
Publicado: (2018)

A High-Affinity CDR-Grafted Antibody against Influenza A H5N1 Viruses Recognizes a Conserved Epitope of H5 Hemagglutinin
por: Xiong, Feifei, et al.
Publicado: (2014)

Kinetics of Neutralizing Antibodies in Patients Naturally Infected by H5N1 Virus
por: Buchy, Philippe, et al.
Publicado: (2010)

Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus
por: Buchy, Philippe, et al.
Publicado: (2011)

Localization of epitopes recognized by monoclonal antibodies that neutralized the H3N2 influenza viruses in man
por: Okada, Jun, et al.
Publicado: (2011)

Comparison of the Protective Efficacy of Neutralizing Epitopes of 2009 Pandemic H1N1 Influenza Hemagglutinin
por: Peng, Bo, et al.
Publicado: (2017)

Seraching for the ${5}H$ Resonance in the t+n+n System
por: Meister, M, et al.
Publicado: (2003)

SARS and H5N1
por: Bindenagel Šehović, Annamarie
Publicado: (2017)

Emergence and spread of novel H5N8, H5N5 and H5N1 clade 2.3.4.4 highly pathogenic avian influenza in 2020
por: Lewis, Nicola S., et al.
Publicado: (2021)

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses
por: Li, Tingting, et al.
Publicado: (2022)

Immunogenicity and Protective Efficacy of a Live Attenuated H5N1 Vaccine in Nonhuman Primates
por: Fan, Shufang, et al.
Publicado: (2009)

Construction of recombinant baculoviruses expressing hemagglutinin of H5N1 avian influenza and research on the immunogenicity
por: Ge, Jingping, et al.
Publicado: (2016)

A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
por: Temperton, Nigel J., et al.
Publicado: (2007)

Neutralizing immune responses induced by oligomeric H5N1-hemagglutinins from plants
por: Phan, Hoang Trong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1d2mm8iu1h0idi7vlsv1d10pg4